New SAMHSA rule reduces required consent for substance abuse records

Why This Topic Matters

The rule may change day-to-day record-sharing workflows for organizations that handle substance use disorder information, while also affecting privacy compliance, consent management, and electronic health record documentation practices.

Article Sections

1. Overview of the final rule

   Introduces the federal rulemaking and explains the general topic of substance use disorder record confidentiality. It frames the article’s focus on consent handling and privacy requirements.

2. Background on Part 2 records and prior consent requirements

   Describes the regulatory context for substance use disorder records and how the earlier framework differed from general HIPAA handling. It sets out the broader compliance environment addressed by the rule.

3. Changes to consent and re-disclosure

   Summarizes the new approach to patient consent and downstream handling of records. It discusses the kinds of organizational arrangements affected by the rule.

4. Patient consent scope and provider responsibilities

   Explains the article’s discussion of how consent parameters relate to later record handling. It also covers the responsibilities placed on providers when managing disclosures.

5. Additional rule adjustments

   Covers smaller revisions included in the final rule, including document notice language used in electronic records. It addresses operational details rather than broad policy changes.

6. Stakeholder reaction and possible future rulemaking

   Summarizes reactions from affected organizations and the broader policy debate around substance use disorder record privacy. It also notes references to possible future changes and further alignment efforts.